Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
The revolving hospital door for HF and sensory-implant guides to cut hospitalization risk
Posted Jun 02, 2010
at 05:30 PM, EDT
by Eric Topol
Two new studies make important contributions to the goal of reducing risk of hospitalization and readmission for HF patients.
What are your thoughts? Are we making progress in the care of patients hospitalized for HF? How can we lower hospital readmission rates in HF? Do you think new sensory devices will improve care?
See:
Trends in HF hospitalization outcomes: A mixed bag
The Revolving Door at the Hospital The Wall Street Journal, June 2, 2010.
Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010; 303:2141-2147.
CHAMPION: "Swan-Ganz" sensor implant guides HF meds, cuts hospitalization risk
Previous posts
Taking point-of-care genetic testing closer to mainstream
4 Comments |
Posted Apr 11, 2012
at 09:27 AM, EDT by Steven
at 09:27 AM, EDT by Steven
Statins and diabetes: A hard look at the data
43 Comments |
Posted Mar 01, 2012
at 05:25 PM, EDT by Eric
at 05:25 PM, EDT by Eric
Talking about a (healthcare) revolution: The digital age ushers in precision medicine
9 Comments |
Posted Jan 25, 2012
at 11:25 AM, EDT by Eric
at 11:25 AM, EDT by Eric
An important miscue in clopidogrel pharmacogenomics
13 Comments |
Posted Dec 27, 2011
at 04:00 PM, EDT by Eric
at 04:00 PM, EDT by Eric
Big-time progress in cardiovascular genomics
1 Comments |
Posted Oct 11, 2011
at 01:05 PM, EDT by Steven
at 01:05 PM, EDT by Steven
Also from theheart.org
Blogs I read
Who's talking
|
Eric J Topol MD
Director, Scripps Translational Science Institute The Gary and Mary West Chair of Innovative Medicine Chief Academic Officer, Scripps Health La Jolla, CA |















Comments
Dr. Topol,
1. Premature discharge of patients admitted with HF is being aggressively driven by hospital administrators, many of whom receive "grades", compensation, promptions, and accolades that are inversely propostional to ALOS, with HF accounting for the highest number of Medicare admissions every year.
2. In some cases #1 also applies to individual physicians.
3. It has been my observattion that GPs, IMs, and most cardiologists do not treat admitted HF patients aggressively enough, do not follow well-proven heuristics and are not comfortable using recent medications and processes (viz. ultrafiltration, bio-impedence monitoring). Hospitalization is consequently unnecessarily prolonged, unless LOS is then shortened by discharge prior to true euhydration and balancing of electrolytes.
4. Post-discharge patients can frequently be stablized and kept out of the ED/hospital without the installation of an implanted device. The only items required for the prevention of readmission are: a) a digital scale with big numbers in each HF patient's home; b) a nurse; c) a telephone; d) a computer with a list of patient medications and a running record of each patient's physiologic parameters, e) an algorithm by which the nurse is empowered to direct a limited number of treatment options (diuretic dose and frequency, fluld intake, instructions to see their physician...). You get the idea.
5. # 4 only works in the presence of an insightful hospital administration (a rare commodity, indeed) and an inspired Physician Champion with fire in his/her belly to make the system work, oversee quality and institute opportunities for improvement.
It is quite easy to understand these concepts. What is not so easy is understanding why there is such resistance to their implementation.
Jan R. Weber, MD, MBA
FACC, FAHA, FACP
I am a heart patient that recevied n ICD in 2005 and a replacement in 2009. The replacement was due to my ICD's battery losing its strength.
The removal of the old ICD and installation of the CRT-D was completed in less than 6 hours and I was on my way home. I am currently monitored by a wireless device (by my bed) and I will probably not require re-hospitalization. This will reduce the excessive cost of re-hospitalization and hopefully extend my life.
My husband age 62 has had CHF since 12/99 and has had, 3 ICD devices since then. These ICD devices have been changed due to battery life. The last one is now has the pace maker. He is paced 90% of the time. He is now at End Stage Heart Failure and his ICD had been firing at a alarming rate until his physicians put him on a high dose of Amirodarone and Mexiletine to stop the atrial fibalations. We were told by his Cardiologist if the ICD fires twice to go to the hospital. We do this and Hospital admissions, for his ICD has been a hit and miss from the ER Physicians. We are either sent home or he stays several days. With the same conclusion, see your personal doctor or if he stays, he is put on the Hoilter montior and endures blood tests that say "he is within the right numbers" now we go home. We make appointments for physicans and live another day. We do have the wonderful ICD unit that takes his reading every other day, but with us it is a revolving door. I am not sure if Hospitals ER's know how to evulate the ICD's. Especially now with his latest ICD going off twice, we are at a diffucult place in our lives. He stayed 5 days, same conclusion, he has End Stage Heart Failure and now we wait for the ICD to go off.